tractocile injection 37.5mg/5ml infusion
ferring gmbh germany wittland 11, 24019 kiel germany - atosiban - infusion - 37.5mg/5ml - atosiban
tractocile concentrate for solution for infusion solution for injection
ferring international center sa, switzerland - atosiban - solution for injection - 7.5 mg/ml
tractocile solution for injection
ferring international center sa, switzerland - atosiban - solution for injection - 7.5 mg/ml
cyclodynon tablets film-coated
bionorica se - agnus castus dry extract - tablets film-coated - 4mg
atosiban hybio 37.5 mg/5 ml konzentrat zur herstellung einer infusionslösung
atosiban hybio 6,75 mg/0,9 ml injektionslösung
tractocile
pharmaco (nz) ltd - atosiban acetate 7.95 mg/ml equivalent to 7.5 mg atosiban per ml - solution for injection - 7.5 mg/ml - active: atosiban acetate 7.95 mg/ml equivalent to 7.5 mg atosiban per ml excipient: hydrochloric acid mannitol water for injection - indicated to delay imminent pre-term birth in pregnant women with: · regular uterine contractions of at least 30 seconds duration at a rate of greater than or equal to 4 per 30 minutes · a cervical dilation of 1 cm to 3 cm (0-3 for nulliparas) and effacement of greater than or equal to 50% · age greater than or equal to 18 years · a gestational age from 24 until 33 completed weeks · a normal foetal heart rate
atosiban g&g pharma 37,5 mg/5 ml konzentrat zur herstellung einer infusionslösung
atosiban g&g pharma 6,75 mg/0,9 ml injektionslösung
atosiban accord 6,75 mg/0,9 ml injektionslösung in einer fertigspritze